Target Name: SOX1
NCBI ID: G6656
Review Report on SOX1 Target / Biomarker Content of Review Report on SOX1 Target / Biomarker
SOX1
Other Name(s): SRY-box transcription factor 1 | SRY (sex determining region Y)-box 1 | SOX-1 | SRY-related HMG-box gene 1 | Transcription factor SOX-1 | SRY-box 1 | SOX1_HUMAN

SOX1: A Non-Coding RNA Molecule Regulating Cell Growth, Apoptosis and Tissue Development

SOX1 (SRY-box transcription factor 1) is a non-coding RNA molecule that plays a crucial role in the development and progression of various diseases, including cancer. SOX1 is a key regulator of gene expression and has been implicated in the regulation of various diseases cellular processes, including cell growth, differentiation, and apoptosis.

SOX1 is a transcription factor, which means it plays a vital role in regulating gene expression in cells. It is a protein that is composed of two distinct domains: a N-terminal domain and a C-terminal domain. The N-terminal domain is responsible for the formation of a complex with other proteins, which allows it to interact with DNA and regulate gene expression. The C-terminal domain is responsible for the protein's stability and functions as a scaffold to recruit chromatin-remodeling complexes to the site of gene expression.

SOX1 is a critical regulator of cell growth and has been shown to play a role in the regulation of cell cycle progression. It is research has shown that SOX1 plays a vital role in the regulation of G1 cell cycle progression by promoting the stagnation in the G1 phase and the start of the S-phase. This is important for the regulation of cell growth and the development of cancer.

SOX1 is also a regulator of cell apoptosis, which is the process by which cells undergo programmed cell death. It is research shows that SOX1 plays a critical role in the regulation of cell apoptosis by promoting the execution of programmed cell death in response to various stressors , including ionizing radiation and chemotherapy.

SOX1 is also involved in the regulation of stem cell maintenance and proliferation. It is research shows that SOX1 plays a vital role in the regulation of stem cell self-renewal and proliferation by promoting the execution of the stem cell cycle and the formation of a stem cell-specific gene expression profile.

In addition to its role in cell growth and apoptosis, SOX1 is also involved in the regulation of tissue development and regeneration. It is research showing that SOX1 plays a critical role in the regulation of tissue development and regeneration by promoting the execution of stem cell- specific gene expression profiles and the formation of tissues with specific functions.

In conclusion, SOX1 is a non-coding RNA molecule that plays a crucial role in the development and progression of various diseases, including cancer. Its regulation of gene expression and cellular processes is a key factor in the regulation of cell growth, apoptosis, stem cell maintenance and regeneration. Therefore, SOX1 is a potential drug target and a biomarker for various diseases, including cancer.

Protein Name: SRY-box Transcription Factor 1

Functions: Transcriptional activator. May function as a switch in neuronal development. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity)

The "SOX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1 | SOX3 | SOX30 | SOX30P1 | SOX4 | SOX5 | SOX5-AS1 | SOX6 | SOX7 | SOX8 | SOX9 | SOX9-AS1 | SP1 | SP100 | SP110 | SP140 | SP140L | SP2 | SP2-AS1 | SP3 | SP3P | SP4 | SP5 | SP6 | SP7 | SP8 | SP9 | SPA17 | SPAAR | SPACA1 | SPACA3 | SPACA4 | SPACA5 | SPACA6 | SPACA6-AS1 | SPACA7 | SPACA9 | SPACDR | SPAG1 | SPAG11A | SPAG11B | SPAG16 | SPAG16-DT | SPAG17 | SPAG4 | SPAG5 | SPAG5-AS1 | SPAG6 | SPAG7 | SPAG8 | SPAG9 | SPAM1 | SPANXA1 | SPANXA2-OT1 | SPANXB1 | SPANXB2 | SPANXC | SPANXD | SPANXN1 | SPANXN2 | SPANXN3 | SPANXN4 | SPANXN5 | SPARC | SPARCL1 | SPART | SPART-AS1 | SPAST | SPATA1 | SPATA12 | SPATA13 | SPATA13-AS1 | SPATA16 | SPATA17 | SPATA18 | SPATA19 | SPATA2 | SPATA20 | SPATA20P1 | SPATA21 | SPATA22 | SPATA24 | SPATA25 | SPATA2L | SPATA3 | SPATA3-AS1 | SPATA31A1 | SPATA31A2